ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Nebraska » Rheumatology

Top Rheumatology Prescribers in Nebraska

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
KENT BLAKELY MD

Rheumatology

9,915

$653K

623
513 are 65+

7%
patients receiving schedule two controlled substances

Avg: 2%

20%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 22%

$66
Average prescription price

Avg: $87

WILLIAM PALMER M.D.

Rheumatology

6,809

$446K

618
506 are 65+

2%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 22%

$66
Average prescription price

Avg: $87

ROBERT VALENTE M.D.

Rheumatology

6,172

$459K

479
426 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 22%

$74
Average prescription price

Avg: $87

DEBORAH DOUD M.D.

Rheumatology

5,652

$435K

410
320 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

17%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 22%

$77
Average prescription price

Avg: $87

JAY KENIK M.D.

Rheumatology

5,522

$758K

558
355 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 22%

$137
Average prescription price

Avg: $87

MELVIN CHURCHILL M.D.

Rheumatology

4,805

$273K

541
438 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 22%

$57
Average prescription price

Avg: $87

STEVEN WEES M.D.

Rheumatology

4,515

$246K

328
269 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

18%
patients receiving schedule three controlled substances

Avg: 9%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 22%

$54
Average prescription price

Avg: $87

DAVID SWIFT M.D.

Rheumatology

4,474

$668K

485
362 are 65+

2%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 22%

$149
Average prescription price

Avg: $87

ALAN JACOBS M.D.

Rheumatology

4,167

$333K

369
291 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

17%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 22%

$80
Average prescription price

Avg: $87

RICK CHATWELL M.D.

Rheumatology

3,993

$228K

334
301 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 22%

$57
Average prescription price

Avg: $87

JOHN HURLEY M.D.

Rheumatology

3,295

$407K

361
232 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 22%

$124
Average prescription price

Avg: $87

LORETTA BACA M.D.

Rheumatology

3,029

$279K

202
155 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

15%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 22%

$92
Average prescription price

Avg: $87

AMY GARWOOD M.D.

Rheumatology

2,668

$288K

276
205 are 65+

13%
patients receiving schedule two controlled substances

Avg: 2%

17%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 22%

$108
Average prescription price

Avg: $87

MARCUS SNOW MD

Rheumatology

2,628

$119K

347
261 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 9%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 22%

$45
Average prescription price

Avg: $87

KATHRYN WILDY M.D.

Rheumatology

2,191

$221K

199
126 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

18%
patients receiving schedule three controlled substances

Avg: 9%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 22%

$101
Average prescription price

Avg: $87

VERNON GARWOOD M.D.

Rheumatology

2,165

$270K

169
141 are 65+

14%
patients receiving schedule two controlled substances

Avg: 2%

17%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 22%

$125
Average prescription price

Avg: $87

VAIDA STOIK MD

Rheumatology

1,526

$155K

179
138 are 65+

7%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 22%

$102
Average prescription price

Avg: $87

JENNIFER ELLIOTT MD

Rheumatology

1,507

$126K

161
109 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 22%

$84
Average prescription price

Avg: $87

JAMES ODELL MD

Rheumatology

1,059

$157K

119
98 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 22%

$148
Average prescription price

Avg: $87

ALAN ERICKSON MD

Rheumatology

820

$112K

103
70 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 22%

$136
Average prescription price

Avg: $87

KRISTIN LAKE M.D.

Rheumatology

816

$103K

66
42 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 22%

$126
Average prescription price

Avg: $87

MAGDALENA FIKSINSKI M.D.

Rheumatology

388

$16.5K

45
27 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 22%

$43
Average prescription price

Avg: $87

AMY CANNELLA MD

Rheumatology

337

$60.4K

37
24 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 22%

$179
Average prescription price

Avg: $87

TED MIKULS MD

Rheumatology

325

$26.4K

47
36 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 22%

$81
Average prescription price

Avg: $87

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank